All G scores China approval for synthetic lactoferrin

Sydney-based biotech All G has achieved a world-first in gaining access to the potentially lucrative Chinese market for its synthetic but bioidentical bovine lactoferrin, produced in bioreactors to replicate an immune-bolstering protein that exists in small doses in milk but is abundant in human…